Crossref
Can amylin weight-loss drugs compete in a world of GLP-1s?
C&EN Global Enterprise · 20.04.2026 · 104 (5) · 52-57
DOI: 10.1021/cen-10405-feature3 ↗Kurz gefasst
Fachartikel in der Zeitschrift C&EN Global Enterprise, online erschienen am 20.04.2026. Verfasst von Aayushi Pratap.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pratap, A. (2026). Can amylin weight-loss drugs compete in a world of GLP-1s?. C&EN Global Enterprise, 104(5), 52-57. https://doi.org/10.1021/cen-10405-feature3
Vancouver
Pratap A. Can amylin weight-loss drugs compete in a world of GLP-1s?. C&EN Global Enterprise. 2026;104(5):52-57. doi:10.1021/cen-10405-feature3
BibTeX
@article{Pratap2026,
author = {Pratap, Aayushi},
title = {Can amylin weight-loss drugs compete in a world of GLP-1s?},
journal = {C&EN Global Enterprise},
year = {2026},
volume = {104},
number = {5},
pages = {52--57},
doi = {10.1021/cen-10405-feature3}
}
EUVIMED